Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
Phase I Study of MK-4166, an Anti-Human Glucocorticoid-Induced Tumor Necrosis Factor Receptor Antibody, Alone or With Pembrolizumab in Advanced Solid TumorsClin. Cancer Res 2020 Dec 21;[EPub Ahead of Print], KP Papadopoulos, KA Autio, T Golan, K Dobrenkov, E Chartash, Q Chen, R Wnek, GV Long
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.